Cover Image
Market Research Report

Meningococcal vaccines: Epidemiology and patient-based market forecasts, treatment algorithm, and marketed and pipeline drug analysis

Published by Datamonitor Healthcare Product code 365206
Published Content info 161 Pages
Delivery time: 1-2 business days
Price
Back to Top
Meningococcal vaccines: Epidemiology and patient-based market forecasts, treatment algorithm, and marketed and pipeline drug analysis
Published: June 1, 2016 Content info: 161 Pages
Description

The recent inclusion of premium-priced meningococcal B (MenB) vaccines into the routine immunization schedules of the US, Italy, and the UK is set to drive strong market growth, which will be further boosted by the anticipated launch of GlaxoSmithKline's pentavalent MenABCW-135Y vaccine from 2021.

This report addresses the following questions:

  • Which vaccine classes are forecast to be the most successful in each of the US and five major EU markets (France, Germany, Italy, Spain, and the UK)?
  • How will vaccination rates for meningococcal disease change over the forecast period?
  • Which risk groups are the most lucrative in each of the US and five major EU markets?
  • Why have France, Germany, and Spain refused to recommend routine MenB vaccination, and how should GlaxoSmithKline address payer concerns?
  • How will the launch of MenABCW-135Yimpact the use of standalone meningococcal ACWY (MenACWY) and MenB vaccines?
Table of Contents
Product Code: DMKC10644

TABLE OF CONTENTS

FORECAST: MENINGOCOCCAL VACCINES

  • 1. Executive Summary
  • 2. Market Overview and Trends
  • 3. Market Definition
  • 4. US Market Forecast
  • 5. France Market Forecast
  • 6. Germany Market Forecast
  • 7. Italy Market Forecast
  • 8. Spain Market Forecast
  • 9. UK Market Forecast
  • 10. Key Opinion Leader Research

MARKETED DRUGS: MENINGOCOCCAL VACCINES

  • 11. Executive Summary
  • 12. Product Overview
  • 13. Product profile: Bexsero
  • 14. Product profile: Menactra
  • 15. Product profile: Menveo
  • 16. Product profile: Trumenba

PIPELINE: MENINGOCOCCAL VACCINES

  • 17. Executive Summary
  • 18. Clinical Pipeline Overview
  • 19. Product profile (late stage): Men Quad TT
  • 20. Product profile (late stage): MenABCW-135Y
Back to Top